Combination of ranibizumab with photodynamic therapy vs ranibizumab monotherapy in the treatment of age-related macular degeneration:a systematic review and meta-analysis of randomized controlled trials

Combination of ranibizumab with photodynamic therapy vs ranibizumab monotherapy in the treatment of age-related macular degeneration:a systematic review and meta-analysis of randomized controlled trials

<b>AIM</b>:To compare the efficacy and safety of combination of ranibizumab with photodynamic therapy (PDT) <i>vs</i> ranibizumab monotherapy in the treatment of age-related macular degeneration (AMD).<b>METHODS</b>:The Cochrane Central Register of Controlled Tria...

Full description

Bibliographic Details
Main Authors: Jun-Kang Si, Kai Tang, Hong-Sheng Bi, Da-Dong Guo, Jun-Guo Guo, Yu-Xiang Du, Yan Cui, Xue-Mei Pan, Ying Wen, Xing-Rong Wang
Format: Article
Language:English
Published: Press of International Journal of Ophthalmology (IJO PRESS) 2014-06-01
Series:International Journal of Ophthalmology
Subjects:
ranibizumab
photodynamic therapy
age-related macular degeneration
meta-analysis
Online Access:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067674/

Internet

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067674/

Similar Items